Summary of the latest UK guidance on infection prevention and control measures for COVID-19
Summarised information on offering HCV antibody testing in community pharmacy
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
This concise consultation card was developed by Guidelines for Pharmacy in partnership with RB UK.
Essential information and adverse reporting details are included.
RB-M-30635 February 2021